• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Brian Woodfall - Articles and news items

Janssen Pharmaceuticals Logo

New data from Phase 3 attain study of Janssen’s once-daily simeprevir compared to telaprevir in treatment-experienced adult patients with genotype 1 chronic hepatitis C

Industry news / 19 March 2014 / Janssen

Additional Phase 3 data from the QUEST-1, QUEST-2 and PROMISE studies explore potential of simeprevir in genotype 1 hepatitis C patients while new ATTAIN data demonstrate a superior safety profile for simeprevir…

Janssen Pharmaceuticals Logo

European Commission approves PREZISTA® (darunavir) 800mg tablet once a day

Industry news, News / 16 January 2013 / prnewswire.co.uk

The European Commission has approved a new PREZISTA® (darunavir) 800mg tablet…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +